— Know what they know.
Not Investment Advice

BLEVF OTC

Beleave Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -90.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · $566 mcap · 547M float · 0.0029% daily turnover

Income Trends

Revenue
$2M +0.0% ▲
Gross Profit
$816K +0.0% ▲
Operating Income
-$23M -122.7% ▼
Net Income
-$34M -167.2% ▼
EPS (Diluted)
$-0.08 -56.4% ▼
EBITDA
-$21M -101.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2014FY2015FY2016FY2017FY2018
Revenue$0$0$0$0$2M
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$2M
Gross Profit$0$0$0$0$816K
Gross Margin————34.4%
R&D Expenses$82K$56K$19K$151K$12K
SG&A Expenses$379K$3M$8M$10M$22M
Operating Expenses$460K$3M$9M$11M$25M
Operating Income-$460K-$3M-$9M-$11M-$23M
Operating Margin————-989.3%
Interest Expense$0$0$0$0$128K
Income Before Tax-$510K-$3M-$9M-$13M-$34M
Tax Expense$0$0$0$0$0
Net Income-$510K-$3M-$9M-$13M-$34M
Net Margin————-1423.0%
EPS (Diluted)$-0.01$-0.03$-0.06$-0.05$-0.08
EBITDA-$410K-$3M-$8M-$10M-$21M
Shares Outstanding88M97M151M239M409M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms